Identification of nine lncRNAs signature for predicting survival benefit of melanoma patients treated with immune checkpoint inhibitors

Zhou JG, Ma H, Gaipl U (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Annals of Oncology Elsevier

Publisher: ELSEVIER

City/Town: AMSTERDAM

Pages Range: S1361-S1361

Conference Proceedings Title: ANNALS OF ONCOLOGY

DOI: 10.1016/j.annonc.2020.10.298

Authors with CRIS profile

Udo Gaipl Department of Radiation Oncology

Involved external institutions

Zunyi Medical University CN China (CN)

How to cite

APA:

Zhou, J.-G., Ma, H., & Gaipl, U. (2020). Identification of nine lncRNAs signature for predicting survival benefit of melanoma patients treated with immune checkpoint inhibitors. In ANNALS OF ONCOLOGY (pp. S1361-S1361). AMSTERDAM: ELSEVIER.

MLA:

Zhou, J-G., H. Ma, and Udo Gaipl. "Identification of nine lncRNAs signature for predicting survival benefit of melanoma patients treated with immune checkpoint inhibitors." Proceedings of the ESMO Asia Virtual Congress AMSTERDAM: ELSEVIER, 2020. S1361-S1361.

BibTeX: Download